| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |